Inhibition of HIV‐1 reverse transcriptase and virus replication by a non‐nucleoside dipyridodiazepinone BI‐RG‐587 (nevirapine)
- 1 January 1992
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 12 (1) , 27-40
- https://doi.org/10.1002/med.2610120103
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinonesJournal of Medicinal Chemistry, 1991
- Inhibition of Human Immunodeficiency Virus Type I (HIV-I) Replication by the Dipyridodiazepinone BI-RG-587The Journal of Infectious Diseases, 1991
- BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudineAntimicrobial Agents and Chemotherapy, 1991
- A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding siteBiochemistry, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Mechanism of HIV reverse transcriptase: enzyme-primer interaction as revealed through studies of a dNTP analog, 3'-azido-dTTPBiochemistry, 1990
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Pirenzepine A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in Peptic Ulcer Disease and Other Allied DiseasesDrugs, 1985
- A detailed model of reverse transcription and tests of crucial aspectsCell, 1979